Patents by Inventor Samirah Gomes

Samirah Gomes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GHRH agonists for the treatment of ischemic disorders
    Patent number: 10555987
    Abstract: Disclosed herein are compositions of GHRH agonists and peptides, and methods to treat disorders, such as ischemia and reperfusion injury. In one embodiment, a method of treating a reperfusion injury in a subject in need may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In additional embodiment, a method of promoting vasculogenesis in a mammal may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In a further embodiment, a method of promoting differentiation of mesenchymal stem cells into endothelial cells may involve contacting mesenchymal stem cells with at least one GHRH agonist peptide.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: February 11, 2020
    Assignees: UNIVERSITY OF MIAMI, U.S.A., REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Andrew Schally, Joshua M. Hare, Norman Block, Samirah Gomes, Rosemeire M. Kanashiro-Takeuchi
  • GHRH AGONISTS FOR THE TREATMENT OF ISCHEMIC DISORDERS
    Publication number: 20180250358
    Abstract: Disclosed herein are compositions of GHRH agonists and peptides, and methods to treat disorders, such as ischemia and reperfusion injury. In one embodiment, a method of treating a reperfusion injury in a subject in need may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In additional embodiment, a method of promoting vasculogenesis in a mammal may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In a further embodiment, a method of promoting differentiation of mesenchymal stem cells into endothelial cells may involve contacting mesenchymal stem cells with at least one GHRH agonist peptide.
    Type: Application
    Filed: November 21, 2017
    Publication date: September 6, 2018
    Inventors: Andrew Schally, Joshua M. Hare, Norman Block, Samirah Gomes, Rosemeire M. Kanashiro-Takeuchi
  • GHRH agonists for the treatment of ischemic disorders
    Patent number: 9855312
    Abstract: Disclosed herein are compositions of GHRH agonists and peptides, and methods to treat disorders, such as ischemia and reperfusion injury. In one embodiment, a method of treating a reperfusion injury in a subject in need may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In additional embodiment, a method of promoting vasculogenesis in a mammal may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In a further embodiment, a method of promoting differentiation of mesenchymal stem cells into endothelial cells may involve contacting mesenchymal stem cells with at least one GHRH agonist peptide.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: January 2, 2018
    Assignees: UNIVERSITY OF MIAMI, THE UNITED STATES OF AMERICA, REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Andrew V. Schally, Joshua M. Hare, Norman L. Block, Samirah A. Gomes, Rosemeire M. Kanashiro-Takeuchi
  • RENAL STEM CELLS ISOLATED FROM KIDNEY
    Publication number: 20140271578
    Abstract: A novel renal precursor cell is identified from kidney tissue. The cell is multipotent capable of forming renal epithelial and endothelial tissues. The cell can be amplified in culture and maintains stemness over multiple passages. This cell fulfills a major unmet need as a cell-based source for kidney regeneration or repair. Treatment of kidney diseases and disorders (e.g., glomerularpathies and acute tubular necrosis) may be improved thereby.
    Type: Application
    Filed: October 1, 2012
    Publication date: September 18, 2014
    Inventors: Joshua M. Hare, Samirah Gomes, Erika B. Rangel
  • GHRH AGONISTS FOR THE TREATMENT OF ISCHEMIC DISORDERS
    Publication number: 20140179604
    Abstract: Disclosed herein are compositions of GHRH agonists and peptides, and methods to treat disorders, such as ischemia and reperfusion injury. In one embodiment, a method of treating a reperfusion injury in a subject in need may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In additional embodiment, a method of promoting vasculogenesis in a mammal may involve administering a therapeutically effective amount of at least one GHRH agonist peptide to the subject. In a further embodiment, a method of promoting differentiation of mesenchymal stem cells into endothelial cells may involve contacting mesenchymal stem cells with at least one GHRH agonist peptide.
    Type: Application
    Filed: December 23, 2013
    Publication date: June 26, 2014
    Applicants: U.S.A., REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, UNIVERSITY OF MIAMI
    Inventors: Andrew V. SCHALLY, Joshua M. HARE, Norman L. BLOCK, Samirah A. GOMES, Rosemeire M. KANASHIRO-TAKEUCHI